On Invalid Date, Phio Pharmaceuticals (NASDAQ: PHIO) reported Q1 2023 earnings per share (EPS) of -$3.15, up 34.62% year over year. Total Phio Pharmaceuticals earnings for the quarter were -$3.60 million. In the same quarter last year, Phio Pharmaceuticals's earnings per share (EPS) was -$2.34.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.